share_log

BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer Gayer Charles K

BioCryst製藥 | 4:持股變動聲明-首席商務官 Gayer Charles K

SEC announcement ·  2023/12/20 16:38
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息